A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatmentNorishige Yoshikawa, Kazumoto Iijima, Koichi Nakanishi et al.|Kidney International|2014Cited by 135
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndromeXiaoyuan Jia, Yuji Kano, Rasheed Gbadegesin et al.|Kidney International|2020Cited by 74
Strong Association of the HLA-DR/DQ Locus with Childhood Steroid-Sensitive Nephrotic Syndrome in the Japanese PopulationXiaoyuan Jia, Kazumoto Iijima, Tomoko Horinouchi et al.|Journal of the American Society of Nephrology|2018Cited by 74
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic SyndromeKazumoto Iijima, Mayumi Sako, Mari S. Oba et al.|Institutional Repositories DataBase (IRDB)|2022Cited by 57
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCTNorishige Yoshikawa, Yuko Shima, Koichi Nakanishi et al.|Pediatric Nephrology|2018Cited by 35